CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $641,403 | -9.7% | 21,772 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $710,203 | -97.8% | 21,772 | -97.7% | 0.00% | -97.8% |
| Q1 2023 | $33,010,754 | -57.7% | 938,072 | -44.9% | 0.18% | -60.6% |
| Q4 2022 | $77,973,635 | -0.7% | 1,701,738 | +5.0% | 0.46% | +7.1% |
| Q3 2022 | $78,539,000 | -11.0% | 1,621,038 | -27.8% | 0.43% | -9.8% |
| Q2 2022 | $88,208,000 | +27.3% | 2,245,038 | +19.3% | 0.48% | +44.0% |
| Q1 2022 | $69,298,000 | -29.9% | 1,882,599 | -13.3% | 0.33% | -32.4% |
| Q4 2021 | $98,924,000 | +1.3% | 2,170,342 | -20.6% | 0.49% | +8.3% |
| Q3 2021 | $97,669,000 | +71.6% | 2,732,775 | -5.0% | 0.46% | +96.6% |
| Q2 2021 | $56,916,000 | -2.1% | 2,876,000 | +15.0% | 0.23% | -19.7% |
| Q1 2021 | $58,150,000 | +16.6% | 2,500,000 | +4.2% | 0.29% | -3.7% |
| Q4 2020 | $49,872,000 | +7.1% | 2,400,000 | +11.6% | 0.30% | -6.8% |
| Q3 2020 | $46,548,000 | +31.7% | 2,150,000 | +43.3% | 0.32% | +13.8% |
| Q2 2020 | $35,355,000 | +379.8% | 1,500,000 | +140.0% | 0.28% | +349.2% |
| Q1 2020 | $7,369,000 | – | 625,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |